Absci (ABSI) Cash from Investing Activities (2020 - 2026)
Absci's (ABSI) quarterly Cash from Investing Activities came in at $7.4 million in Q1 2026, up 148.94% year-on-year from $3.0 million in Q1 2025, and down 62.34% quarter-over-quarter from $19.5 million in Q4 2025.
Absci (ABSI) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Absci has disclosed Cash from Investing Activities across 7 years of filings, most recently posting $7.4 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at $7.4 million, up 148.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.8 million (down 238.35% YoY), and the FY2025 annual result was -$50.2 million, down 20.64% from the prior year.
- Cash from Investing Activities came in at $7.4 million for Q1 2026 at Absci, down from $19.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $70.2 million in Q2 2023 to a low of -$78.7 million in Q3 2022.
- The 5-year median for Cash from Investing Activities is $1.3 million (2024), against an average of -$7.6 million.
- Across the five-year window, Cash from Investing Activities slumped 1054.3% in 2022 and surged 725.07% in 2023, its largest moves.
- Absci's Cash from Investing Activities stood at -$30.2 million in 2022, then soared by 162.82% to $19.0 million in 2023, then advanced by 0.45% to $19.0 million in 2024, then climbed by 2.65% to $19.5 million in 2025, then tumbled by 62.34% to $7.4 million in 2026.
- The last three Cash from Investing Activities figures came in at $7.4 million (Q1 2026), $19.5 million (Q4 2025), and -$63.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 579,519.10 |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - | 7.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.36 Mn |
| Mar 31, 2026 | 7.36 Mn |
| Dec 31, 2025 | 19.55 Mn |
| Dec 31, 2025 | 19.55 Mn |
| Sep 30, 2025 | -63.70 Mn |
| Sep 30, 2025 | -63.70 Mn |
| Jun 30, 2025 | 9.04 Mn |
| Jun 30, 2025 | 9.04 Mn |
| Mar 31, 2025 | -15.04 Mn |
| Mar 31, 2025 | -15.04 Mn |
| Dec 31, 2024 | 19.04 Mn |
| Dec 31, 2024 | 19.04 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Sep 30, 2024 | 14.81 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.26 Mn |
| Mar 31, 2024 | -76.68 Mn |
| Mar 31, 2024 | -76.68 Mn |
| Dec 31, 2023 | 18.96 Mn |
| Dec 31, 2023 | 18.96 Mn |